ZBSO treatment resulted in an increase in the Bax/Bcl-2 ratio from 1.03 to 2.89 (p < 0.05), which suggests that ZBSO may promote apoptosis in human melanoma A375 cells. The gene discussed is BCL2; the disease is melanoma.